HOME >> MEDICINE >> NEWS
New alzheimer's drug shows promise in clinical trial

Washington, DC--The only drugs currently available for Alzheimer's patients are those that alleviate symptoms, but a team of scientists led by Paul Aisen, MD, director of the Memory Disorders program at Georgetown University Medical Center, is testing a new class of drugs that actually target the molecule believed to cause the disease. Aisen and his colleagues report that a compound called tramiprosate reduced levels of a marker for the progression of Alzheimer's disease in a Phase II clinical trial in the November 1 electronic version of Neurology.

"Everyone wants to figure out how to create an Alzheimer's treatment that attacks the amyloid peptide, which is considered to be the molecular cause of the disease," said Aisen. "This is the most advanced anti-amyloid treatment that exists--it has the potential for slowing down progression of the disease."

Aisen and his team are currently in the midst of Phase III clinical trials on tramiprosate (manufactured by Neurochem, for which Aisen is a scientific advisor, as ALZHEMEDTM) and hope to have results by early next summer. Media should call 202-687-5100 to schedule an interview with Aisen or to be connected with another Georgetown expert on the topic.


'"/>

Contact: Becky Wexler
rjw43@georgetown.edu
202-687-5100
Georgetown University Medical Center
2-Nov-2006


Page: 1

Related medicine news :

1. New study shows promise in reducing surgical risks associated with surgical bleeding
2. Most seniors now have drug coverage, U-M study shows
3. Wireless technology shows promise in diagnosing pediatric intestinal disease
4. Study shows radiofrequency ablation highly effective in treating kidney tumors
5. Method shows promise for early detection of pancreatic cancer
6. Organic farming can feed the world, U-M study shows
7. New study shows Rescue Remedy is an effective all-natural stress, anxiety reliever
8. Borderline personality disorder shows improvements with intensive psychotherapy
9. New drug shows promise in treatment of advanced thyroid cancer
10. Study shows Diachrome improves blood sugar control in people with type 2 diabetes
11. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... ... October 16, 2018 , ... 13th Annual FDA Inspections ... , The 13th Annual FDA Inspections Summit starts in one week. , ... difficult to keep up. The FDA is focused on any number of new ...
(Date:10/16/2018)... ... ... The months of training are over. The race has come and gone. It doesn’t matter ... put through the wringer after the big event. Read on for something healthy hints from ... how to treat the body and mind after a long run: , 1. Don’t sit. ...
(Date:10/13/2018)... ... October 12, 2018 , ... At HEI Health, we believe ... will be attending this year’s National Healthcare CXO Fall Summit by Marcus Evans. HEI ... Patient Access and Patient Experience challenges with leading healthcare providers. , Marcus Evans ...
(Date:10/13/2018)... ... October 13, 2018 , ... This World Food Day – Tuesday, October ... possible to end hunger by 2030 by breaking a GUINNESS WORLD RECORDS title with ... 28 U.S. based locations and five international locations together to break the GUINNESS WORLD ...
(Date:10/11/2018)... ... October 11, 2018 , ... ... medalists are leading scientists in their fields recognized by DuPont Nutrition & Health ... technology relevant to the future of food, nutrition and health. , This year’s ...
Breaking Medicine News(10 mins):
(Date:10/17/2018)... ... 2018 , ... Sri Lanka Export Development Board, the country’s apex ... Development Authority are organising pavilions at SIAL International Food Fair to be held in ... world’s largest food innovation exhibition, SIAL 2018 international Food Fair is estimated to draw ...
(Date:10/17/2018)... ... October 17, 2018 , ... ... care management technology solutions, today announced that its GuidingCare® platform (Version 8.7+) ... Accreditation. The review process included a rigorous evaluation of GuidingCare’s Population Health ...
(Date:10/16/2018)... ... October 16, 2018 , ... SightMD (or the “Company”), a leading multi-specialty ophthalmology ... with Mid Island Eye Physicians & Surgeons (“Mid Island Eye” or “MIE”). The ... over 50 physicians and 25 convenient locations in New York. , For more ...
Breaking Medicine Technology:
Cached News: